Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine – A Prospective Observational Study

BACKGROUND: Since the introduction of various vaccines against SARS-CoV-2 at the end of 2020, infection rates have continued to climb worldwide. This led to the establishment of a third dose vaccination in several countries, known as a booster. To date, there has been little real-world data about th...

Descripción completa

Detalles Bibliográficos
Autores principales: Herzberg, Jonas, Fischer, Bastian, Becher, Heiko, Becker, Ann-Kristin, Honarpisheh, Human, Guraya, Salman Yousuf, Strate, Tim, Knabbe, Cornelius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286388/
https://www.ncbi.nlm.nih.gov/pubmed/35844588
http://dx.doi.org/10.3389/fimmu.2022.896151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286388/
https://www.ncbi.nlm.nih.gov/pubmed/35844588
http://dx.doi.org/10.3389/fimmu.2022.896151

Ejemplares similares